Accelerate Diagnostics, Inc. is a pharmaceutical company. The Company is focused on developing and commercializing instrumentation for the identification and antibiotic susceptibility testing of infectious pathogens. The Company�s BACcel platform utilizes a proprietary culture-free process with both genomic and phenotypic detection technologies. The Company�s BACcel system includes a fixed instrument and proprietary single-use test cassettes. Each cassette tests a single patient specimen and is then discarded. BACcel uses long-accepted bacteriological testing principles, but applies its technology to adapt them to analyze live bacteria extracted directly from a patient specimen. The Company�s other product includes OptiChem, which is used in micro arraying components. OptiChem offers noise rejection (non-specific binding by interfering substances) and capacity for target binding. OptiChem also offers the ability to apply micro-patterns, enabling analyzer designs.